FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

ASTRAZEN Share Price Discussion

AstraZeneca Pharma India Ltd.
Sector: Pharmaceuticals and health care
... Read more
ASTRAZEN Share Price *
2,766.5 +114.4 (4.31%)
* (quote may be delayed)

Find answers to all your questions on live ASTRAZEN message board: Is ASTRAZEN buy or sell? Should I buy ASTRAZEN shares? Why are ASTRAZEN shares falling? Should I invest in ASTRAZEN stock?


You can also check ASTRAZEN share price target recommended by brokerages.

ASTRAZEN Discussion Forum


*Astrazeneca Pharma India Ltd.* | *CMP* Rs. 2666 | *M Cap* Rs. 6665 Cr | *52 W H/L* 2774/1306
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 208.5 Cr (1.9% QoQ, 29.2% YoY) vs QoQ Rs. 204.6 Cr, YoY Rs. 161.4 Cr
EBIDTA came at Rs. 33.3 Cr (-6.4% Qo...
Read more...
Like
reply
Reply
share
Share

Astrazeneca Pharma India Sept Quarter Profit Rises
Nov 11 (Reuters) - Astrazeneca Pharma India Ltd
SEPT QUARTER PROFIT 144.2 MILLION RUPEES VERSUS PROFIT OF 91.3 MILLION RUPEES YEAR AGO
SEPT QUARTER REVENUE FROM OPERATIONS 2.08 BILLION RUPEES VERSUS 1.61 BILLION RUPEES YEAR AGO
1
reply
Reply (1)
share
Share
Latest replies
Sahasra @sahasra
Nov 12 2:51 PM

Thanks for sharing
HALAL INVESTMENT in ASTRAZEN
ASTRAZEN....2774

ASTRAZEN...2809
HOLD 4 TARGET
Like
reply
Reply
share
Share
HALAL INVESTMENT in ASTRAZEN
ASTRAZEN....2717+ HOLD 4 TARGET OR BK 50%

ASTRAZEN....2774
Like
reply
Reply
share
Share
HALAL INVESTMENT in ASTRAZEN
ASTRAZEN....2551 BUY RANGE....2520/2400 CBSL......

ASTRAZEN....2717+
HOLD 4 TARGET OR BK 50%
Like
reply
Reply
share
Share

ASTRAZEN....2551
BUY RANGE....2520/2400
CBSL...2352
EXPECT...3000/3200+
1
reply
Reply
share
Share
These 30 stocks outperformed BSE 500, rallied 20-60% in an eventful September
Auto, bank, capital goods, consumer durables, energy, FMCG and metal sectors were among key gainers, while healthcare, IT and realty took a beating in September.
Moneycontrol
Like
reply
Reply
share
Share
AstraZeneca Pharma rises 4% on permission from DCGI
The receipt of this permission paves way for the launch of FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets (QTERN) in India.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: DHFL, Cipla, GSK Pharma, Sterlite Tech, Future Enterprises, CG Power, SRF
DHFL | Cipla | GlaxoSmithKline Pharma | Adani Enterprises | Future Enterprises and Sterlite Technologies are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, CG Power, SRF
DHFL | Cipla | GlaxoSmithKline Pharma | Adani Enterprises | Future Enterprises and Sterlite Technologies are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, Sterlite Tech
DHFL | Cipla | GlaxoSmithKline Pharma | Adani Enterprises | Future Enterprises and Sterlite Technologies are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Trade Setup for Thursday: Top 15 things to know before Opening Bell
According to the pivot charts, key support level for Nifty is placed at 11,382.53, followed by 11,324.87. If the index starts moving up, key resistance levels to watch out for are 11,531.43 and 11,622.67.
Moneycontrol
Like
reply
Reply
share
Share

ASTRAZEN ROCKSSSSSSSSSS HIT 2068
Like
reply
Reply
share
Share

BUY ASTRAZEN ABOVE 2046 SL 1950
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

Positional:
# Astrazeneca pharma cmp : 2257 _ strong buy ( add on dips till 1940)
Tgt 3600-4000
Tym frame : 18 -24 months

Any one who is luking out for positional long term/midterm portfolio build-up can subcribe for the same link mentioned.

Refer : Asm market views
Like
reply
Reply
share
Share
  • ASTRAZEN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,995.75
    Enterprise Value4,822.45
    Price to Earnings89.09
    Price to Book Value16.6
    Return on Capital Employed0.18
    Return on Equity0.11
    Face Value2
    Dividend YieldNA
  • ASTRAZEN Share Price - Technicals

    keyboard_arrow_down
    ASTRAZEN - 52 Week High₹2,865.9
    ASTRAZEN - 52 Week Low₹1,320
  • ASTRAZEN - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    30-Nov-17Rudra Shares & Stocks BrokersBuy1,420
    ASTRAZEN Brokerage Price Target
  • ASTRAZEN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 9265527882645.252764.45
    Dec 62720.1277326402652.1
    Dec 52740276826752717.85
    Dec 428002833.3527252745.05
    Dec 328392865.92760.32790.75
  • ASTRAZEN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,677.36
    30 Day Moving Average₹2,648.68
    50 Day Moving Average₹2,482.32
    100 Day Moving Average₹2,194.44
    200 Day Moving Average₹2,112.36
  • ASTRAZEN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue571539.570.06
    Operating Profit4629.380.57
    Profit Before Tax4433.20.33
    Net Income2624.440.06
  • ASTRAZEN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3012470.22
    Total Liabilities2612150.21
    Total Assets5624620.22
  • ASTRAZEN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity938.31-0.77
    Cash from Investing Activity-90.25-37
    Cash from Financing ActivityNA-0.22-1
    Net Cash Flow-138.35-1.03
  • ASTRAZEN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.060.06
    Return on Equity0.110.14
    Return on Capital Employed0.180.18
  • ASTRAZEN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.1
    3 Year CAGR Growth in Operating Profit5.03
    3 Year CAGR Growth in EBIDTA11.61
    3 Year CAGR Growth in Net Income2.25
    3 Yr CAGR Growth - Diluted EPS2.26
  • ASTRAZEN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.46
    5 Year CAGR Growth in Operating Profit1.67
    5 Year CAGR Growth in EBIDTA2.02
    5 Year CAGR Growth in Net Income1.29
    3 Yr CAGR Growth - Diluted EPS1.29
  • ASTRAZEN - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 1 4:58 PM
    These 30 stocks outperformed BSE 500, rallied 20-60% in an eventful September
    Moneycontrol
    NewsBot
    Sep 26 5:43 PM
    AstraZeneca Pharma rises 4% on permission from DCGI
    Moneycontrol
    NewsBot
    Sep 26 1:58 PM
    Stocks in the news: DHFL, Cipla, GSK Pharma, Sterlite Tech, Future Enterprises, CG Power, SRF
    Moneycontrol
    NewsBot
    Sep 26 1:43 PM
    Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, CG Power, SRF
    Moneycontrol
    NewsBot
    Sep 26 1:18 PM
    Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, Sterlite Tech
    Moneycontrol
    NewsBot
    Sep 26 2:18 AM
    Trade Setup for Thursday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Jul 8 12:43 AM
    NewsBot
    May 25 12:58 AM
    NewsBot
    Apr 4 3:23 AM
    NewsBot
    Mar 28 3:38 PM
  • ASTRAZEN - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.